Prediction of sudden arrhythmic death following acute myocardial infarction

Area of Science:

• Cardiology
• Cardiac Electrophysiology
• Preventive Cardiology

Background:

• Patients surviving acute myocardial infarction (AMI) face ongoing risk of sudden cardiac death (SCD).
• Current risk stratification for implantable cardioverter defibrillator (ICD) insertion primarily relies on left ventricular ejection fraction (LVEF).
• Suboptimal risk assessment may lead to under- or over-utilization of ICDs in AMI survivors.

Purpose of the Study:

• To review current evidence on advanced cardiovascular tests for risk stratification in AMI survivors.
• To evaluate the utility of these tests in guiding ICD recipient selection.
• To discuss the advantages and limitations of various risk assessment modalities.

Main Methods:

• Systematic review of existing literature on ECG-based tests (signal-averaged ECG, T-wave alternans), Holter-based recordings (heart rate variability, heart rate turbulence), and cardiac magnetic resonance imaging.
• Analysis of recent findings on 12-lead ECG indices and genetic profiling for risk prediction.
• Comparative assessment of the pros and cons of each diagnostic tool.

Main Results:

• Left ventricular ejection fraction is a primary but insufficient predictor of SCD risk in AMI survivors.
• ECG-based tests, Holter monitoring, and cardiac MRI offer complementary information on myocardial substrate abnormalities.
• Emerging data suggest value in novel ECG indices and genetic markers for enhanced risk prediction.

Conclusions:

• Advanced cardiovascular tests can significantly refine risk stratification in AMI survivors compared to LVEF alone.
• These methods aid in more accurate patient selection for ICD implantation, potentially improving outcomes.
• Further research is warranted to integrate these diverse tools into clinical practice for optimal SCD prevention.